WASHINGTON, Jan. 30, 2024 /PRNewswire/ Danaher Corporation today announced results for the fourth quarter and full year 2023. All results in this release reflect only continuing operations.
Coagulo Medical Technologies
Thursday, December 24, 2020 2:15PM IST (8:45AM GMT)
Cambridge, Mass., United States:
Coagulo Medical Technologies, an MIT-born startup that has developed the world’s first precision-medicine platform for comprehensive and targeted blood clotting management, today announced it has raised $6.5 million in financing from 20/20 HealthCare Partners, Sands Capital, Good Growth Capital, IAG Capital Partners and private investors. The Boston area diagnostics innovator also announced that it has been awarded a Small Business Innovation Research (SBIR) grant by the National Science Foundation to accelerate delivery of breakthrough innovations amid the global COVID–19 public health crisis, which has called attention to the limitations of conventional coagulation tests.